http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114534658-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_02b011622fa2eb7b4992cd0cae398561
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J2204-002
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J4-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-718
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-539
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-9066
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-285
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-537
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01F35-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-9066
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J4-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J19-00
filingDate 2022-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9f522712083f4635e7ad86b131d93ea
publicationDate 2022-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-114534658-A
titleOfInvention A kind of lung cancer drug production device and its drug formula
abstract The invention discloses a lung cancer drug production device and a drug formula thereof. The lung cancer drug preparation formula proposed in the technical solution can inhibit tumor effect, immune enhancement effect, analgesia and anti-stress effect, and combined chemotherapy with synergistic effect and detoxification effect. That is to say, the use of combined chemotherapy can significantly enhance the efficacy of chemotherapy, reduce the dose of chemotherapy drugs, and can effectively reduce chemotherapy's inhibition of white blood cells, platelets, bone marrow and damage to the myocardium and liver, enhance the function of the reticuloendothelial system, and promote hematopoietic function; Promote the re-differentiation of cancer cells; inhibit the carcinogenic toxicity: and by setting up corresponding production devices, that is, through the regulating mechanism and the equal proportioning control mechanism, the precise proportioning of various ingredients can be regulated to ensure the quality of the processed products. actual treatment needs.
priorityDate 2022-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID105117
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453763408

Total number of triples: 33.